Attached files
| file | filename |
|---|---|
| EX-10.27.4 - EX-10.27.4 - ALBIREO PHARMA, INC. | albo-ex10274_603.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_11.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_7.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | albo-ex231_8.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | albo-ex211_280.htm |
| EX-10.28 - EX-10.28 - ALBIREO PHARMA, INC. | albo-ex1028_403.htm |
| EX-10.25 - EX-10.25 - ALBIREO PHARMA, INC. | albo-ex1025_282.htm |
| EX-10.11 - EX-10.11 - ALBIREO PHARMA, INC. | albo-ex1011_281.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-10k_20171231.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2017 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: March 27, 2018 |
|
/s/ Ronald H.W. Cooper |
|
|
|
Ronald H.W. Cooper |
|
|
|
President and Chief Executive Officer (principal executive officer) |
|
Dated: March 27, 2018 |
|
/s/ Thomas A. Shea |
|
|
|
Thomas A. Shea |
|
|
|
Chief Financial Officer and Treasurer (principal financial officer and principal accounting officer) |